2021
DOI: 10.15585/mmwr.mm7043e2
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
75
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 95 publications
(83 citation statements)
references
References 8 publications
7
75
0
1
Order By: Relevance
“…Another surveillance system, the VSD, showed no increased risk of non-COVID-19 mortality in vaccinated people. 47 This study has several strengths, including the large population under surveillance and the comprehensive capture of national data from two complementary surveillance systems. Because the US Government purchased all COVID-19 doses and collected administration data, we were able to calculate VAERS reporting rates using the number of mRNA vaccine doses administered as denominators.…”
Section: Discussionmentioning
confidence: 99%
“…Another surveillance system, the VSD, showed no increased risk of non-COVID-19 mortality in vaccinated people. 47 This study has several strengths, including the large population under surveillance and the comprehensive capture of national data from two complementary surveillance systems. Because the US Government purchased all COVID-19 doses and collected administration data, we were able to calculate VAERS reporting rates using the number of mRNA vaccine doses administered as denominators.…”
Section: Discussionmentioning
confidence: 99%
“…The chances of most of these outcomes were much greater and lasted longer after SARS-CoV-2 exposure than after vaccination [ 13 ]. Obviously, the benefits of obtaining a COVID-19 vaccine still outweigh the risks; the mortality [ 114 ], thrombocytopenia and thrombosis [ 115 , 116 ] risks of COVID-19 are still much greater.…”
Section: Discussionmentioning
confidence: 99%
“…Efficiency of ATG16L depletion using a specific shRNA (Sigma) expressed from an integrated lentiviral vector is depicted. Four different cell lines were established using four different shRNAs (14) to deplete ATG16L and the cell line expressing shRNA #2 was selected as depletion of ATG16L was more efficient. E. Vero E6 + γ 1 34.5 cells were treated with doxycycline for 48 h to induce γ 1 34.5 expression, as above.…”
Section: Resultsmentioning
confidence: 99%